Dr. Matt Vesely is an Assistant Professor of Dermatology at Yale School of Medicine. His laboratory focuses on understanding the immunopathogenesis of autoimmune skin diseases, particularly cutaneous lupus erythematosus and lichen planus.

Owns stock in Regeneron; Consultant to SunPharma, HiFiBio, & Priovant; will discuss off-label uses.